These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6163720)

  • 21. The involvement of Lyt-2 antigens in the lysis of virus-infected target cells by antigen specific anti-vesicular stomatitis virus cytotoxic T-lymphocytes.
    Hale AH
    Immunol Lett; 1981 Aug; 3(3):179-81. PubMed ID: 6169636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reconstitution with T lymphocytes protects nude mice from a central nervous system disorder induced by a temperature-sensitive vesicular stomatitis virus.
    Doll SC; Johnson TC
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1969-77. PubMed ID: 2841409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
    Sheil JM; Bevan MJ; Lefrancois L
    J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory.
    Bründler MA; Aichele P; Bachmann M; Kitamura D; Rajewsky K; Zinkernagel RM
    Eur J Immunol; 1996 Sep; 26(9):2257-62. PubMed ID: 8814275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells.
    Forman J; Goodenow RS; Hood L; Ciavarra R
    J Exp Med; 1983 Apr; 157(4):1261-72. PubMed ID: 6187888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity in mice of temperature-sensitive mutants of vesicular stomatitis virus: early appearance in bronchial secretions of an interferon-like inhibitor.
    Beatrice ST; Wagner RR
    J Gen Virol; 1980 Apr; 47(2):529-33. PubMed ID: 6154132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal.
    Fehr T; Bachmann MF; Bluethmann H; Kikutani H; Hengartner H; Zinkernagel RM
    Cell Immunol; 1996 Mar; 168(2):184-92. PubMed ID: 8640864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic T lymphocytes reactive with vesicular stomatitis virus: analysis of specificity with monoclonal antibodies directed to the viral glycoprotein.
    Lefrancois L; Lyles DS
    J Immunol; 1983 Mar; 130(3):1408-12. PubMed ID: 6185583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer cell response to lymphocytic choriomeningitis virus in beige mice.
    Welsh RM; Kiessling RW
    Scand J Immunol; 1980; 11(4):363-7. PubMed ID: 6155687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of vesicular stomatitis virus in athymic nude mice: mutations associated with natural killer cell selection.
    Vandepol SB; Holland JJ
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():441-51. PubMed ID: 3005478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elicitation of anti-vesicular stomatitis virus cytotoxic T lymphocytes by using purified viral and cellular antigens incorporated into phospholipid vesicles.
    Ruebush MJ; Hale AH; Harris DT
    Infect Immun; 1981 May; 32(2):513-7. PubMed ID: 6265359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a competitive enzyme-linked immunosorbent assay for detection of bovine, ovine, porcine, and equine antibodies to vesicular stomatitis virus.
    Afshar A; Shakarchi NH; Dulac GC
    J Clin Microbiol; 1993 Jul; 31(7):1860-5. PubMed ID: 8394377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
    Zinkernagel RM; Althage A; Holland J
    J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer cells vs cytotoxic T cells in the peripheral blood of virus-infected mice.
    Stitz L; Althage A; Hengartner H; Zinkernagel R
    J Immunol; 1985 Jan; 134(1):598-602. PubMed ID: 2981094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
    Harris DT; Hale AH; Lefrancois L
    J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of a secondary antibody response to vesicular stomatitis virus "G" protein by IFN-gamma treatment at primary immunization.
    Anderson KP; Fennie EH; Yilma T
    J Immunol; 1988 May; 140(10):3599-604. PubMed ID: 2834443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus.
    Roost H; Charan S; Gobet R; Rüedi E; Hengartner H; Althage A; Zinkernagel RM
    Eur J Immunol; 1988 Apr; 18(4):511-8. PubMed ID: 2452742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses in interleukin-2-deficient mice.
    Kündig TM; Schorle H; Bachmann MF; Hengartner H; Zinkernagel RM; Horak I
    Science; 1993 Nov; 262(5136):1059-61. PubMed ID: 8235625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses.
    Bachmann MF; Kündig TM; Kalberer CP; Hengartner H; Zinkernagel RM
    J Virol; 1993 Jul; 67(7):3917-22. PubMed ID: 8389912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
    Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
    J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.